Hidradenitis suppurativa/acne inversa. An update

被引：23

作者：

Kirschke, J. ^{[1
]}

Hessam, S. ^{[2
]}

Bechara, F. G. ^{[2
]}

机构：

[1] HELIOS St Elisabeth Klin Oberhausen, Klin Dermatol Venerol & Allergol, Oberhausen, Germany

[2] Klin Ruhr Univ Bochum, St Josef Hosp, Abt Dermatochirurg, Klin Dermatol Venerol & Allergol, D-44791 Bochum, Germany

来源：

HAUTARZT | 2015年 / 66卷 / 06期

关键词：

Inflammatory disease; Treatment outcome; Therapy; Diagnosis; Excision; SQUAMOUS-CELL CARCINOMA; CONTROLLED CROSSOVER TRIAL; LABEL CLINICAL-TRIAL; ACNE INVERSA; GAMMA-SECRETASE; DOUBLE-BLIND; TNF-ALPHA; CHROMOSOME; 1P21.1-1Q25.3; CYPROTERONE-ACETATE; SURGICAL-TREATMENT;

D O I：

10.1007/s00105-015-3616-y

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Hidradenitis suppurativa/acne inversa (HS/AI) is a chronic inflammatory disease characterized by painful nodules, abscesses, fistulas, sinus tracts and scarring, which may lead to severe functional and psychological impairment. Patients often suffer for many years before the right diagnosis is finally made. HS/AI is still a therapeutic challenge. Conservative therapies play a role in mild stages of the disease; however they do not result in healing. Therapy of choice associated with the lowest recurrence rate is a radical wide excision of involved skin.

引用

页码：413 / 422

页数：10

共 119 条

[1]

Adams DR, 2010, ARCH DERMATOL, V146, P501, DOI 10.1001/archdermatol.2010.72

[2] Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region [J].

Al-Ali, Faiza Mohamed Saleh ;

Ratnamala, Uppala ;

Mehta, Timir Y. ;

Naveed, Mohammad ;

Al-Ali, Mahmoud T. ;

Al-Khaja, Najib ;

Sheth, Jayesh J. ;

Master, Dilipkumar C. ;

Maiti, Amit K. ;

Chetan, Ghati K. ;

Nath, Swapan K. ;

Radhakrishna, Uppala .

EXPERIMENTAL DERMATOLOGY, 2010, 19 (09) :851-853

[3] Hidradenitis suppurativa: A comprehensive review [J].

Alikhan, Ali ;

Lynch, Peter J. ;

Eisen, Daniel B. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (04) :539-561

[4] A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa [J].

Amano, Masahiro ;

Grant, Annika ;

Kerdel, Francisco A. .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (08) :950-955

[5] Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy [J].

Arenbergerova, Monika ;

Gkalpakiotis, Spyridon ;

Arenberger, Petr .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 2010, 49 (12) :1445-1449

[6]

Barth JH, 1996, BRIT J DERMATOL, V134, P1057

[7] Acne inversa [J].

Bechara, F. G. ;

Hartschuh, W. .

HAUTARZT, 2010, 61 (01) :39-46

[8] Acne Inversa: Evaluating Antimicrobial Peptides and Proteins [J].

Bechara, Falk G. ;

Sand, Michael ;

Skrygan, Marina ;

Kreuter, Alexander ;

Altmeyer, Peter ;

Gambichler, Thilo .

ANNALS OF DERMATOLOGY, 2012, 24 (04) :393-397

[9]

BENDAHAN J, 1992, EUR J SURG, V158, P213

[10] Systemic therapy with immunosuppressive agents and retinoids in hidradenitis suppurativa: a systematic review [J].

Blok, J. L. ;

van Hattem, S. ;

Jonkman, M. F. ;

Horvath, B. .

BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (02) :243-252

← 1 2 3 4 5 6 7 8 9 10 →